REFERENCES

1. Gurumurthy M, Cruickshank ME. Management of vaginal intraepithelial neoplasia. J Low Genit Tract Dis 2012;16:306-12.

2. Cramer DW, Cutler SJ. Incidence and histopathology of malig­nancies of the female genital organs in the United States.

3. Lenehan PM, Meff F, Lickrish GM. Vaginal intraepithelial neo­plasia: biologic aspects and management. Obstet Gynecol 1986;68:333-37.

4. Rome RM, England PG. Management of vaginal intraepithelial neoplasia: a series of 132 cases with long term follow-up. Int J Gynecol Cancer 2000;10:382-90.

5. Aho M, Vesterinen E, Meyer B, Purola E, Paavonen J. Natural his­tory of vaginal intraepithelial neoplasia. Cancer 1991;68:195-97.

6. Abercrombie PD, Korn AP. Lower genital tract neoplasia in women with HIV infection. Oncology (Williston Park) 1998;12:1735-39.

7. Gemmell J, Holmes DM, Duncan ID. How frequently need vaginal smears be taken after hysterectomy for cervical intraepithelial neoplasia? Br J Obstet Gynecol 1990;97:58-61.

8. Hoffman DS, DeCesare SL, Roberts WS, Fiorica JV, Finan MA, Cavanagh D. Upper vaginectomy for in situ and occult, super­ficially invasive carcinoma of the vagina. Am J Obstet Gynecol 1992;166:30-33.

9. Curtis P, Shepherd JH, Lowe DG, Jobling T. The role of partial colpectomy in the management of persistent vaginal neoplasia after primary treatment. Br J Obstet Gynaecol 1992;99:587-89.

10. Diakomanolis E, Rodolakis A, Boulgaris Z, Blachos G, Michalas S. Treatment of vaginal intraepithelial neoplasia with laser ablation and upper vaginectomy. Gynecol Obstet Invest 2002;54:17-20.

11. Benedet JL, Wilson PS, Matisic JP. Epidermal thickness measure­ments in vaginal intraepithelial neoplasia. A basis for optimal CO2 laser vaporization. J Reprod Med 1992;37:809-12.

12. Lin H, Huang EY, Chang HY, ChangChien CC. Therapeutic ef­fect of topical applications of trichloracetic acid for vaginal intraepithelial neoplasia after hysterectomy.

13. Kirwan P, Naftalin NJ. Topical 5-fluorouracil in the treat­ment of vaginal intraepithelial neoplasia. Br J Obstet Gynaecol 1985;92:287-91.

14. Haidopoulos D, Diakomanolis E, Rodolakis A, Voulgaris Z, Vlachos G, Insaklis A. Can local application of imiquimod cream be an alternative mode of therapy for patients with high­grade intraepithelial lesions of the vagina? Int J Gynecol Cancer 2005;15:898-902.

15. David L, Simon L. Colposcopy and Programme Management: Guidelines for the NHS Cervical Screening Programme, 2nd edn. Publication No. 20. London, UK: NHS CSP; 2010.

16. Stokes-Lampard H, Wilson S, Waddell C, Ryan A, Holder R, Kehoe S. Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature. BJOG 2006;113:1354-65.

17. Dodge JA, Eltabbakh GH, Mount SL, Walker RP, Morgan A. Clinical features and risk of recurrence among patients with va­ginal intraepithelial neoplasia. Gynecol Oncol 2001;83:363-69.

18. Reyes MC, Cooper, K. An update on vulvar intraepithelial neo­plasia: terminology and a practical approach to diagnosis. J Clin Pathol 2014;67:290-94.

19. Van Esch EMG, Dam MCI, Osse MEM, et al. Clinical character­istics associated with development of recurrence and progression in usual-type vulvar intraepithelial neoplasia. Int J Gynecol Cancer 2013;23:1476-83.

20. Eva LJ, Ganesan R, Chan KK, et al. Differentiated-type vulval intraepithelial neoplasia has a high-risk association with vulval squamous cell carcinoma. Int J Gynecol Cancer 2009;19:741-44.

21. Eva LJ, Ganesan R, Chan KK, et al. Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases. J Reprod Med 2008;53:397-401.

22. Van de Nieuwenhof HP, van Kempen LC, Massuger LF, et al. Differentiated-type vulval intraepithelial neoplasia has a high- risk association with vulval squamous cell carcinoma. Int J Gynecol Cancer 2010;20:194.

23. Lloyd J, Flanagan AM. Mammary and extramammary Paget’s dis­ease. J Clin Pathol 2000;53:742-49.

24. Bornstein J, Bogliatto F, Haefner H, et al. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) termin­ology of vulvar squamous intraepithelial lesions. J Low Genit Tract Dis 2016;20:11-14.

25. Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005;50:807-10.

26. Darragh TM, Colgan TJ, Thomas Cox J, et al. Members of the LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 2013;32:76-115.

27. Edwards L. Pigmented vulvar lesions. Dermatol Ther 2010; 23:449-57.

28. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001;20:16-30.

29. Van der Burg S, Palefsky JM. Human immunodeficiency virus and human papilloma virus—why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med 2009;7:108.

30. Pinto AP, Miron A, Yassin Y, et al. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is

31. Rolfe KJ, Maclean AB, Crow JC, et al. TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer 2003;89:2249-53.

32. Del Pino M, Rodriguez-Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology 2013;62:161-75.

33. McNally OM, Mulvany NJ, Pagano R, et al. VIN3: a clinicopathologic review. Int J Gynecol Cancer 2002;12:490-95.

34. Eva LJ. Screening and follow up of vulval skin disorders. BestPract Res Clin Obstet Gynaecol 2012;26:175-88.

35. Jones RW, Joura EA.

36. Husseinzadeh N, Recinto C. Frequency of invasive cancer in surgically excised vulvar lesions with intraepithelial neoplasia (VIN3). Gynecol Oncol 1999;73:119-20.

37. Rufforny I, Wilkinson EJ, Liu C, et al. Human papillomavirus infec­tion and p16 (INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma. J Lower Genit TractDis 2005;9:108-13.

38. McCluggage WG. Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 2002;40:309-26.

39. Jones RW, Rowan D. VIN3: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar car­cinoma. Obstet Gynecol 1994;84:741-45.

40. Lawrie TA, Nordin A, Chakrabarti M, Bryant A, Kaushik S, Pepas L. Medical and surgical interventions for the treatment of usual­type vulval intraepithelial neoplasia. Cochrane Database Syst Rev 2016;1:CD011837.

41. Cruickshank ME, Hay I, Guidelines Committee of the Royal College of Obstetricians and Gynaecologists (RCOG). The Management of Vulval Skin Disorders. Green-top Guideline No. 58. London: RCOG; 2011.

42. Jones RW. The natural history of cervical and vulvar intraepithelial neoplasia. Am J Obstet Gynecol 2010;202:e12-13.

43. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neo­plasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 2005;106:1319-26.

44. National Cancer Institute. Surveillance, epidemiology, and end results program. Available at: http://seer.cancer.gov/statfacts/ html/vulva.html.

45. Akhtar-Danesh N, Elit L, Lytwyn A. Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study. Gynecol Oncol 2014;134:314-18.

46. Somoye GO, Mocroft A, Olaitan A. Analysis of the incidence and mortality of vulval cancer in women in South East England 1960­1999.

47. Del Pino M, Rodriquez-Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology 2013;62:161-75.

48. Van der Avoort IA, Shirango H, Hoevenaars BM, et al. Vulvar squa­mous cell carcinoma is a multifactorial disease following two sep­arate and independent pathways. IntJ Gynecol Pathol 2006;25:22-29.

49. Pinto AP, Miron A, Yassin Y, et al. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma. Mod Pathol 2010;23:404-12.

50. Prodratz KC, Symmonds RE, Taylor WF, Williams TJ. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983;61:63-74.

51. Hopkins MP, Reid GC, Johnston CM, Morley GW. A comparison of staging systems for squamous cell carcinoma of the vulva. Gynecol Oncol 1992;47:34-37.

52. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984;63:155-62.

53. Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecologic and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group study). Am J Obstet Gynecol 1991;164:997-1003.

54. Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol 1992;45:313-16.

55. Paladini D, Cross P, Lopes A, Monaghan JM. Prognostic signifi­cance of lymph node variables in squamous cell carcinoma of the vulva. Cancer 1994;74:2491-496.

56. Hacker NF. Revised FIGO staging for carcinoma of the vulva. IntJ Gynecol Obstet 2009;105:105-106.

57. Barbera L, Thomas G, Elit L, et al. Treating vulvar cancer in the new millennium: are patients receiving optimal care? Gynecol Oncol 2008;109:71-75.

58. Basset A. Traitement chirurgical operatoire de Fepithelioma primitif du clitoris: Indications, technique, resultats. Rev Chir 1912;46:546-63.

59. Taussig FJ. Cancer of the vulva: an analysis of 155 cases (1911­1940). Am J Obstet Gynecol 1949;40:764-772.

60. Way S. Carcinoma of the vulva. Am J Obstet Gynecol 1960;79:692-97.

61. Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate incisions. Obstet Gynecol 1981;58:574-79.

62. Hacker NF, van der Velden J. Conservative management of early vulvar cancer. Cancer 1993;71:1673-77.

63. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983;16:179-83.

64. Burger MP, Hollema H, Bouma J. The side of groin node me­tastases in unilateral vulvar carcinoma. In J Gynecol Cancer 1996;6:318-22.

65. Wills A, Obermair A. A review of complications associated with the surgical treatment of vulvar cancer. Gynecol Oncol 2013;131:467-79.

66. Selman TJ, Luesley DM, Acheson N, Khan KS, Mann CH. A sys­tematic review of the accuracy of diagnostic tests for inguinal lymph node status in vulvar cancer. Gynecol Oncol 2005;99:206-14.

67. Oonk MH, Hollema H, de Hullu JA, van der Zee AG. Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer 2006;16:963-71.

68. Cormio G, Loizzi V, Carriero C, Cazzolla A, Putignano G, Selvaggi L. Groin recurrence in carcinoma of the vulva: management and outcome. Eur J Cancer Care 2010;19:302-307.

69. Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 1994;84:163-67.

70. Covens A, Vella ET, Kennedy EB, Reade CJ, Jimenez W, Le T. Sentinel lymph node biopsy in vulvar cancer: systematic review, meta-analysis and guideline recommendations. Gynecol Oncol 2015;137:351-61.

71. Van der Zee AG, Oonk MH, de Hullu JA, et al. Sentinel node dis­section is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;20:884-89.

72. Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell car­cinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 2012;30:3786-91.

73. Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of non-s entinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010;11:646-52.

74. Erickson BK, Divine LM, Leath CA 3rd, Straughn JM Jr. Cost-ef­fectiveness analysis of sentinel lymph node biopsy in the treatment of early- stage vulvar cancer. IntJ Gynecol Cancer 2014;24:1480-85.

75. McCann GA, Cohn DE, Jewell EL, Havrilesky LJ. Lymphatic mapping and sentinel lymph node dissection compared to complete Jymphadenectomy in the management of early-stage vulvar cancer: a cost-utility analysis. Gynecol Oncol 2015;136: 300-304.

76. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with posi­tive groin nodes. Obstet Gynecol 1986;68:733-40.

77. Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol 2009;114:537-46.

78. Fons G, Groenen SM, Oonk MH, et al. Adjuvant radiotherapy in patients with vulvar cancer and one intracapsular lymph node metastasis is not beneficial. Gynecol Oncol 2009;114:343-45.

79. Woelber L, Eulenburg C, Choschzich M, et al. Prognostic role of lymph node metastases in vulvar cancer and implications for ad­juvant treatment. Int J Gynecol Cancer 2012;22:503-508.

80. Gill BS, Bernard ME, Lin JF, et al. Impact ofadjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NSDB) analysis. Gynecol Oncol 2015;137:365-72.

81. Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, et al. ACR appropriateness criteria management of locoregionally advanced squamous cell carcinoma of the vulva. Am J Clin Oncol 2013;36:415-22.

82. Van Doorn HC, Ansink A, Verhaar-Langereis M, Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev 2006;3:CD003752.

83. Moore DH, Ali S, Koh WJ, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gyneco­logic oncology group study. Gynecol Oncol 2012;124:529-33.

84. Te Grootenhuis NC, van der Zee AG, van Doorn HC, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol 2016;140:8-14.

85. Zhou J, Shan G. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis. Curr Med Res Opin 2016;32:1121-30.

86. Oonk MH, de Hullu JA, Hollema H, et al. The value of routine follow-up in patients treated for carcinoma of the vulva. Cancer 2003;98:2624-29.

87. Van Doorn HC, van Beekhuizen HJ, Gaarenstroom KN, et al. Repeat sentinel lymph node procedure in patients with recur­rent vulvar squamous cell carcinoma is feasible. Gynecol Oncol 2016;140:415-19.

88. Nooij LS, Ongkiehong PJ, van Zwet EW, et al. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma. Gynecol Oncol 2015;139:458-64.

89. Moxley KM, Fader AN, Rose PG, et al. Malignant melanoma of the vulva: an extension of cutaneous melanoma? Gynecol Oncol 2011;122:612-17.

90. Philips GL, Bundy BN, Okagaki T, Kucera PR, Stehman FB. Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group. Cancer 1994;73:2626-32.

91. Sladden MJ, Balch C, Barzilai DA, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009;4:CD004835.

92. Abramova L, Parekh J, Irvin WP Jr, et al. Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review. Ann Surg Oncol 2002;9:840-46.

93. Verschraegen CF, Benjapibal M, Supakarapongkul W, et al. Vulvar melanoma at the M.D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer 2001;11:359-64.

94. Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlof B, Nilsson BR, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical obser­vations and histopathologic features. Cancer 1999;86:1273-84.

95. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.

96. Beller U, Benedet JL, Creasman WT, et al. Carcinoma of the vagina. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95 Suppl 1:S29-42.

97. Davis KP, Stanhope CR, Garton GR, Atkinson EJ, O’Brien PC. Invasive vaginal carcinoma: analysis of early-stage disease. Gynecol Oncol 1991;42:131-36.

98. Daling JR, Madeleine MM, Schwartz SM, et al. A population­based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84:263-70.

99. Herman JM, Homesley HD, Dignan MB. Is hysterectomy a risk factor for vaginal cancer? JAMA 1986;256:601-603.

100. Bouma J, Burger MP, Krans M, Hollema H, Pras E. Squamous cell carcinoma of the vagina: a report of 32 cases. Int J Gynecol Cancer 1994;4:389-94.

101. Herbst AL, Robboy SJ, Scully RE, Poskanzer DC. Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol 1974;119:713-24.

102. Gardner CS, Sunil J, Klopp AH, et al. Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol 2015;99:20150033.

103. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vagina; FIGO cancer report 2015. Int J Gynecol Obstet 2015;131 Suppl 2:S84-87.